ISRCTN52513758已完成4 期
Abiraterone acetate plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: multicentre Italian real life” study
rology Department ASL Abruzzo 20 个研究点目标入组 145 人开始时间: 2016年5月23日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 145
研究概览
简要总结
2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29126389 results
研究设计
- 研究类型
- Observational
入排标准
- 性别
- Male
入选标准
- •1. Men over the age of 18
- •2. Biochemically or histologically confirmed progressive mCRPC
- •3. Castrate levels of testosterone (<50 ng/dl)
- •4. Chemonaive
- •5. Eligible for abiraterone acetate
排除标准
- •Does not meet the inclusion criteria
研究者
相似试验
已完成
2 期
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific AntigenProstatic NeoplasmProstate CancerNCT01314118Janssen Biotech, Inc.131
进行中（未招募）
2 期
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate CancerCastration-Sensitive Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8NCT04267887OHSU Knight Cancer Institute7
已完成
1 期
A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate CancerProstate NeoplasmsNCT01017939Janssen Research & Development, LLC34
已完成
1 期
A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate CancerProstate NeoplasmsNCT00910754Janssen Research & Development, LLC33
已完成
3 期
A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based ChemotherapyProstate NeoplasmsNCT01695135Janssen Research & Development, LLC214